GlaxoSmithKline

GSK, MD Anderson Cancer Center to develop new cancer drugs

10 Dec 2012

GSK Consumer Healthcare share buyback opens on 17 January

05 Dec 2012

Glaxo makes open offer to hike stake in Indian arm

26 Nov 2012

The company is offering Rs3,900 per share, a premium of approximately 28 per cent to the company's closing share price on the NSE on Friday

GSK to sell Australian generic portfolio to Aspen Pharma

16 Aug 2012

Human Genome Sciences agrees to GSK's revised $3-bn offer

17 Jul 2012

US biopharmaceutical company Human Genome Sciences yesterday agreed to be acquired by GlaxoSmithKline Plc (GSK) for a sweetened $3 billion

GSK to close Human Genome Sciences acquisition with $2.8-bn revised offer: report

16 Jul 2012

GlaxoSmithKline is close to acquiring Human Genome Sciences for about $2.8 billion, two months after it went hostile with its $2.59-billion bid for the US biopharmaceutical firm

GlaxoSmithKline to pay record $3 billion in US drug fraud case

03 Jul 2012

GlaxoSmithKline plc (GSK) will pay a record $3 billion to various health authorities in the US in the largest healthcare fraud settlement in US history

GSK to buy new eczema drug Toctino from Basilea Pharmaceutica for £146 mn

12 Jun 2012

GlaxoSmithKline extends $2.6 billion offer for Human Genome Sciences

09 Jun 2012

No rival bids have emerged so far since GSK has invested $125 million in an ongoing research partnership with HGS and the two are collaborating on the development of three drugs

Human Genome adopts poison pill to thwart $2.6-bn hostile GSK bid

18 May 2012

HGS, which is GSK's partner on two drug developments, had rejected the UK firm's takeover offer saying that it was an opportunistic move

GlaxoSmithKline goes hostile with its $2.59-bn bid for Human Genome Sciences

09 May 2012

Aspen to buy GSK’s international OTC brands

20 Apr 2012

GlaxoSmithKline’s $2.6-bn bid rejected by Human Genome Sciences

19 Apr 2012

GSK to sell most European OTC drugs to Omega Pharma

15 Mar 2012

GlaxoSmithKline end-quarter 2011 net rises over 18 per cent to Rs137 crore

16 Feb 2012

GSK repatriating funds daily from European operations

08 Feb 2012

GSK to sell some North American OTC drugs to Prestige Brands for $661 mn

21 Dec 2011

GSK to pay $3 bn to settle US investigations for promoting drugs for unapproved uses

03 Nov 2011

Patented drugs overpriced, admits Glaxo CEO Witty

28 Sep 2011

The industry has to strike a balance between delivering innovation and affordable pricing, particularly in emerging markets and least developed countries, says GSK chief executive Andrew Witty.

GSK to pay $40.75 mn to 37 US states to settle sub-standard manufacturing lawsuit

24 Jun 2011

GlaxoSmithKline loses appeal in Rs71.21-crore Drug Price Equalisation Account demand

13 Apr 2011

GlaxoSmithKline to take $3.4-bn legal charge for diabetes drug Avandia

18 Jan 2011

The £2.2-billion charge equates to an after-tax cost of £1.8 billion in GSK's fourth quarter of fiscal 2010.

GlaxoSmithKline acquires rights to Parkinson’s drug from Impax

16 Dec 2010

Glaxo to buy China's specialist drugmaker MeiRui Pharma for $70 million

08 Dec 2010

GlaxoSmithKline plans to acquire China’s Nanjing MeiRui Pharma

02 Dec 2010